Katzenmaier, S. K., Markert, C., Riedel, K., Burhenne, J., Haefeli, W. E., & Mikus, G. (2011). Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using a limited sampling strategy. Clinical pharmacology & therapeutics, 90(5), . https://doi.org/10.1038/clpt.2011.164
Chicago Style (17th ed.) CitationKatzenmaier, Stephanie Katharina, Christoph Markert, Klaus-Dieter Riedel, Jürgen Burhenne, Walter E. Haefeli, and Gerd Mikus. "Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using a Limited Sampling Strategy." Clinical Pharmacology & Therapeutics 90, no. 5 (2011). https://doi.org/10.1038/clpt.2011.164.
MLA (9th ed.) CitationKatzenmaier, Stephanie Katharina, et al. "Determining the Time Course of CYP3A Inhibition by Potent Reversible and Irreversible CYP3A Inhibitors Using a Limited Sampling Strategy." Clinical Pharmacology & Therapeutics, vol. 90, no. 5, 2011, https://doi.org/10.1038/clpt.2011.164.